MedPath

Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)

Phase 3
Completed
Conditions
Lung Cancer
Interventions
Behavioral: Active pain management
Registration Number
NCT01310387
Lead Sponsor
Chonnam National University Hospital
Brief Summary

This study is:

* A single-center, randomized, prospective controlled trial.

* To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.

* 204 patients will be recruited.

Detailed Description

* The recruited patients in both group will be provided the education about pain-killer, and received medicines including opioids according to their numeric rating scale (NRS)

* Active management group will be provided additional telephone counseling and dosage modification by specialized nurse for cancer pain.

* The percent of pain intensity difference (%PID)

* PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
79
Inclusion Criteria
  • Outpatients with lung cancer.
  • The patients with uncontrolled lung cancer pain - more than and equal NRS 4 pain during previous 24 hours for background pain, or more than and equal 3 times/day for breakthrough painkiller medication.
  • Over 20 year-old male or female.
  • The patients can be able to received telephone counseling by investigator's decision.
Exclusion Criteria
  • Drug or alcohol abusers.
  • Child-bearing women or pregnant women.
  • The patients with moderate to severe psychiatric problems.
  • The patients who have hypersensitivity to opioids.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
active pain managementActive pain managementactive pain management (APM) by specialized nurses for cancer pain
Primary Outcome Measures
NameTimeMethod
The percent of pain intensity differencevisit 3 (6 to 8 weeks)

The percent of pain intensity difference (%PID)

%PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1

Secondary Outcome Measures
NameTimeMethod
Patients' satisfaction score about pain managementvisit 3 (6 to 8 weeks)

Qustionnaire of 5-point scale

Eastern Cooperative Oncology Group (ECOG) Performance scorevisit 3 (6 to 8 weeks)

ECOG performance status: 0,1,2,3,4

Assessment of Korean Brief Pain Inventory scorevisit 3 (6 to 8 weeks)

Qustionnaire; K-BPI(Korean Brief Pain Inventory)

Investigator's global assessment scorevisit 3 (6 to 8 weeks)

Qustionnaire of 5-point scale

Trial Locations

Locations (1)

Chonnam National University Hwasun Hospital

🇰🇷

Jeonnam, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath